Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2025-12-31 @ 8:28 PM
Study NCT ID:
NCT01492361
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2011-12-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Sponsor:
Amarin Pharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-13
First Submit QC Date:
None
Study First Post Date:
2011-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-02-08
Results First Submit QC Date:
None
Results First Post Date:
2022-04-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-06-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-21
Last Update Post Date:
2022-04-14
Last Update Post Date Type:
ACTUAL